[CLINICAL AND EXPERIMENTAL REASEARCH ON PROLONGED FIBRINOLYTIC THERAPY. 1. ACTIVATION OF FIBRINOLYSIS BY PROLONGED ADMINISTRATION OF A MONOAMINE OXIDASE INHIBITOR].
D000818:Animals; D001161:Arteriosclerosis; D002784:Cholesterol; D004358:Drug Therapy; D005342:Fibrinolysis; D007793:Lagomorpha; D008996:Monoamine Oxidase Inhibitors; D009526:Nialamide; D010600:Pharmacology; D011817:Rabbits; D012106:Research; D015912:Thrombolytic Therapy
D008996:Monoamine Oxidase Inhibitors; D002784:Cholesterol; D009526:Nialamide
ARTERIOSCLEROSIS; CHOLESTEROL; DRUG THERAPY; EXPERIMENTAL LAB STUDY; FIBRINOLYSIS; NIALAMIDE; PHARMACOLOGY; RABBITS
RECHERCHES CLINIQUES ET EXP'ERIMENTALES SUR LE TRAITEMENT FIBRINOLYTIQUES PROLONG'E 1. ACTIVATION DE LA FIBRINOLYSE PAR L'ADMINISTRATION PROLONG'EE D'UN INHIBITEUR DE LA MONO AMINE OXYDASE.